Suchergebnisse - "Hu, Zhigang"

PubPharm (13)

1

Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells

enthalten in: Medical oncology (Northwood, London, England) | 2023

von Wang, Z. | Yong, C. | Fu, Y. | +4

2

METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma

enthalten in: International journal of oncology | 2022

von Li, M. | Xia, M. | Zhang, Z. | +6

ErratumIn: Int J Oncol. 2023 Sep;63(3):. - PMID 37503727

3

Nilotinib, A Tyrosine Kinase Inhibitor, Suppresses the Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer

enthalten in: Anti-cancer agents in medicinal chemistry | 2022

von Meng, L. | Zhao, P. | Hu, Z. | +4

4

Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer

enthalten in: Investigational new drugs | 2021

von Wang, Y. | Hu, Z. | Ma, W. | +4

5

The Role of PARP Inhibitors in the Treatment of Prostate Cancer : Recent Advances in Clinical Trials

enthalten in: Biomolecules | 2021

von Xia, M. | Guo, Z. | Hu, Z.

6

MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer

enthalten in: Oncogene | 2020

von Lu, X. | Liu, R. | Wang, M. | +5

7

Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1

enthalten in: Molecular cancer therapeutics | 2019

von Zhu, H. | Wu, C. | Wu, T. | +13

8

Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER

enthalten in: Molecular cancer research : MCR | 2019

von Wang, M. | Li, E. | Lin, L. | +6

9

Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells

enthalten in: DNA repair | 2018

von He, L. | Yang, H. | Zhou, S. | +12

10

FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer

enthalten in: Molecular oncology | 2017

von He, L. | Luo, L. | Zhu, H. | +13

ErratumIn: Mol Oncol. 2017 Sep;11(9):1302-1303. - PMID 28861953